β-Catenin-accumulated crypts in the colonic mucosa of juvenile ApcMin/+ mice

Cancer Letters

Volumn 239, Issue 1, 2006, Pages 123-128

  Hata, Kazuya ^a,b   Tanaka, Takuji ^c   Kohno, Hiroyuki ^c   Suzuki, Rikako ^c   Qiang, Sheng Hong ^b   Yamada, Yasuhiro ^b   Oyama, Takeshi ^b   Kuno, Toshiya ^b   Hirose, Yoshinobu ^b   Hara, Akira ^b   Mori, Hideki ^b  

^a Sunplanet Co Ltd   (Japan)

^b GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Catenin accumulated crypts; C57BL 6J ApcMin +; Juvenile mice

Indexed keywords

APC PROTEIN; BETA CATENIN; PROTEIN APC MIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL TUMOR; CONTROLLED STUDY; DESCENDING COLON; FEMALE; INTESTINE CRYPT; MALE; MICROADENOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ANIMALS; ANIMALS, NEWBORN; BETA CATENIN; COLON; COLONIC NEOPLASMS; FEMALE; GENES, APC; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

ANIMALIA;

EID: 33745437862     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.07.033     Document Type: Article

References (25)

1. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 37 (1987) 147-151
2. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 93 (1995) 55-71
3. Siu I.M., Pretlow T.G., Amini S.B., and Pretlow T.P. Identification of dysplasia in human colonic aberrant crypt foci. Am. J. Pathol. 150 (1997) 1805-1813
4. Corpet D.E., and Tache S. Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency, Nutr. Cancer 43 (2002) 1-21
5. Corpet D.E., and Pierre F. Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 391-400
6. Yamada Y., Yoshimi N., Hirose Y., Kawabata K., Matsunaga K., Shimizu M., Hara A., and Mori H. Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res. 60 (2000) 3323-3327
7. Yamada Y., Yoshimi N., Hirose Y., Matsunaga K., Katayama M., Sakata K., Shimizu M., Kuno T., and Mori H. Sequential analysis of morphological and biological properties of β-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res. 61 (2001) 1874-1878
8. Yamada Y., Yoshimi N., Hirose Y., Hara A., Shimizu M., Kuno T., Katayama M., Qiao Z., and Mori H. Suppression of occurrence and advancement of β-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib, Jpn. J. Cancer Res. 92 (2001) 617-623
9. Moser A.R., Pitot H.C., and Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 247 (1990) 322-324
10. Su L.K., Kinzler K.W., Vogelstein B., Preisinger A.C., Moser A.R., Luongo C., Gould K.A., and Dove W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256 (1992) 668-670
11. Oshima M., Oshima H., Kitagawa K., Kobayashi M., Itakura C., and Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA 92 (1995) 4482-4486
12. Hata K., Yamada Y., Kuno T., Hirose Y., Hara A., Qiang S.H., and Mori H. Tumor formation is correlated with expression of β-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Sci. 95 (2004) 316-320
13. Yamada Y., Hata K., Hirose Y., Hara A., Sugie S., Kuno T., Yoshimi N., Tanaka T., and Mori H. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult ApcMin/+ mice. Cancer Res. 62 (2002) 6367-6370
14. Pretlow T.P., Edelmann W., Kucherlapati R., Pretlow T.G., and Augenlicht L.H. Spontaneous aberrant crypt foci in Apc1638N mice with a mutant Apc allele. Am. J. Pathol. 163 (2003) 1757-1763
15. Paulsen J.E., Steffensen I.L., Loberg E.M., Husoy T., Namork E., and Alexander J. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon. Cancer Res. 61 (2001) 5010-5015
16. T. Tanaka, H. Kohno, R. Suzuki, K. Hata, S. Sugie, N. Niho, K. Sakano, M. Takahashi, K. Wakabayashi, Dextran sodium sulfate strongly promotes colorectal carcinogenesis in ApcMin/+ mice: Inflammatory stimuli by dextran sodium sulfate results in development of multiple colonic neoplasms, Int. J. Cancer, in press.
17. Kawabata K., Tanaka T., Murakami T., Okada T., Murai H., Yamamoto T., Hara A., Shimizu M., Yamada Y., Matsunaga K., Kuno T., Yoshimi N., Sugie S., and Mori H. Dietary prevention of azoxymethane-induced colon carcinogenesis with rice-germ in F344 rats. Carcinogenesis 20 (1999) 2109-2115
18. Kinzler K.W., and Vogelstein B. Lessons from hereditary colorectal cancer. Cell 87 (1996) 15-170
19. min mouse model by 1,4-phenylene bis(methylene)selenocyanate. Carcinogenesis 21 (2000) 617-621
20. Paulsen J.E., Namork E., Steffensen I.L., Eide T.J., and Alexander J. Identification and quantification of aberrant crypt foci in the colon of Min mice-a murine model of familial adenomatous polyposis. Scand. J. Gastroenterol. 35 (2000) 534-539
21. Δ716 knockout mice. Cancer Res. 57 (1997) 1644-1649
22. Jacoby R.F., Marshall D.J., Newton M.A., Novakovic K., Tutsch K., Cole C.E., Lubet R.A., Kelloff G.J., Verma A., Moser A.R., and Dove W. Chemoprevention of spontaneous intestinal adenomas in the ApcMin mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56 (1996) 710-714
23. Reitmair A.H., Cai J.C., Bjerknes M., Redston M., Cheng H., Pind M., Hay K., Mitri A., Bapat B., Mak T.W., and Gallinger S. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res. 56 (1996) 2922-2926
24. Suzui M., Okuno M., Tanaka T., Nakagama H., and Moriwaki H. Enhanced colon carcinogenesis induced by azoxymethane in min mice occurs via a mechanism independent of β-catenin mutation. Cancer Lett. 183 (2002) 31-41
25. Philip M., Rowley D.A., and Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin. Cancer Biol. 14 (2004) 433-439